Sign in
4

Changes in Ownership

Celldex Therapeutics, Inc. Filed Acc 0001415889-23-010049

Options or other derivatives

  • SVP, CHIEF MEDICAL OFFICER acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Young Diane C. SVP, CHIEF MEDICAL OFFICER 2023-06-15 Grant or award · Incentive Stock Option (right to buy) +80,000 80,000 D
Loading xslF345X04/form4-06202023_080658.xml…